Clinical Professionals Group and the Apprenticeship Levy

Whilst many are concerning themselves with the UK’s ‘Brexit’ from the EU and the potential negative impacts, Clinical Professionals’ Academies team have been focussing on the positive movements by government to create talented and skilled professionals through apprenticeships to bolster our Life Science economy – something we know a lot about and have been evangelising

Continue Reading

Novartis’ psoriasis trial data for Cosentyx outshines Johnson and Johnson competitor

Novartis has recently released trial data showing that Cosentyx was shown to be significantly more effective in treating patients with psoriasis when compared to the Johnson & Johnson’s rival biologic Stelara. According to the published results from the head-to-head CLARITY study, 66.5% of patients treated with Cosentyx achieved the primary endpoint PASI 90 (a 90%

Continue Reading

UK Biotech given green light to begin stem cell therapy clinical trial for heart failure

UK biotech, Celixir, has received a green light to start a phase IIb trial of HeartCel, its stem cell-based therapy for heart failure, that could potentially support approval. Heartcel is a preparation of off-the-shelf immunomodulatory progenitor (iMP) cells that are injected around cardiac scar tissue during coronary artery bypass graft (CABG) surgery in the hope

Continue Reading

Research by Lancaster Uni shows potential treatment for Alzheimer’s with diabetes drug

Researchers at Lancaster University have identified a type 2 diabetes drug that has shown potential benefit in the treatment of Alzheimer’s disease. The treatment combined three older diabetes drugs to create a “triple agonist”, that combines GLP-1, GIP and glucagon. The belief being that boosting levels of growth hormones will aid in protecting the brain

Continue Reading

Recent study data by the FDA has found that older blood cancer patients (75+) are severely under-represented in clinical trials

Results from the FDA’s first comprehensive examination of clinical trial enrolment in older patients with blood cancers has revealed that patients over 75 are significantly underrepresented. When looking at the occurrence of these conditions, it has recently been found that one in five patients in the US who are diagnosed with blood cancer are over

Continue Reading